Demo Sign up Log In

R&D Expenses

$105.73M

Quarterly · Period ending: Jun 30, 2026 · USD

RMD R&D Expenses

Latest reported$105.73Mperiod endingJun 30, 2026

Latest reported$105.73Mperiod endingJun 30, 2026

RMD Quarterly R&D Expenses ($0.00 → $105.73M)

Quarterly R&D Expenses

High-resolution chart · PNG

RMD r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

ResMed R&D Expenses — Quarterly (USD)
Period ending	R&D Expenses (USD)
Jun 30, 2001	3,235,000
Mar 31, 2001	3,017,000
Dec 31, 2000	2,505,000
Sep 30, 2000	2,389,000
Jun 30, 2000	2,535,000
Mar 31, 2000	2,103,000
Dec 31, 1999	2,000,000
Sep 30, 1999	1,900,000
Jun 30, 1999	1,900,000
Mar 31, 1999	1,500,000
Dec 31, 1998	1,600,000
Sep 30, 1998	1,400,000
Jun 30, 1998	1,200,000
Mar 31, 1998	1,300,000
Dec 31, 1997	1,200,000
Sep 30, 1997	1,300,000
Jun 30, 1997	1,100,000
Mar 31, 1997	1,100,000
Dec 31, 1996	900,000
Sep 30, 1996	800,000
Jun 30, 1996	800,000
Mar 31, 1996	600,000
Dec 31, 1995	0
Sep 30, 1995	0
Jun 30, 1995	0
Mar 31, 1995	0
Dec 31, 1994	0
Sep 30, 1994	0
Jun 30, 1994	0
Mar 31, 1994	0
Dec 31, 1993	0
Sep 30, 1993	0
Jun 30, 1993	0
Mar 31, 1993	0
Dec 31, 1992	0
Sep 30, 1992	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.